DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Reddy K, Zeuzem S, Zoulim F et al.
A Phase III randomised, double-blind study to evaluate the efficacy, safety and tolerability of simeprevir vs telaprevir in combination with pegylated interferon and ribavirin in chronic hepatitis C virus genotype 1 treatment-experienced patients: the ATTAIN study.
Hepatol Int 2014;
8: S397
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.